[Billing Code: 4140-01-P] DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse; Notice of Closed Meetings Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel GMP Synthesis of Bulk Drug Testing Date: July 18, 2024 Time: 2:00 PM to 4:00 PM Agenda: To review and evaluate contract proposals Place: National Institute of Health National Institute on Drug Abuse 301 North Stonestreet Avenue Bethesda, MD 20892 (Virtual Meeting) Contact Person: Meysam Yazdankhah, Ph.D. Scientific Review Officer Scientific Review Branch National Institute on Drug Abuse, NIH 301 North Stonestreet Avenue, MSC 6021 Bethesda, MD 20892 (301) 402-6965 meysam.yazdankhah@nih.gov Name of Committee: National Institute on Drug Abuse Special Emphasis Panel NIDA-L Conflict SEP Date: July 23, 2024 Time: 2:00 PM to 3:30 PM Agenda: To review and evaluate grant applications Place: National Institute of Health National Institute on Drug Abuse 301 North Stonestreet Avenue Bethesda, MD 20892 (Virtual Meeting) Contact Person: Sudhirkumar U. Yanpallewar, M.D. Scientific Review Officer Scientific Review Branch National Institute on Drug Abuse, NIH 301 North Stonestreet Avenue, MSC 6021 Bethesda, MD 20892 (301) 443-4577 sudhirkumar.yanpallewar@nih.gov (Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug Abuse Scientist Development Award for Clinicians, Scientist Development Awards, and Research Scientist Awards; 93.278, Drug Abuse National Research Service Awards for Research Training; 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS) Dated: June 17, 2024. Lauren A. Fleck, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024-13709 Filed: 6/21/2024 8:45 am; Publication Date: 6/24/2024]